

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 9.75977723 |
| 2 | negative regulation by host of viral transcription (GO:0043922) | 5.26472322 |
| 3 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 5.02873309 |
| 4 | positive thymic T cell selection (GO:0045059) | 4.99939369 |
| 5 | pyrimidine nucleoside catabolic process (GO:0046135) | 4.76836547 |
| 6 | positive T cell selection (GO:0043368) | 4.66862592 |
| 7 | actin nucleation (GO:0045010) | 4.65283873 |
| 8 | negative regulation of T cell apoptotic process (GO:0070233) | 4.50067314 |
| 9 | eosinophil chemotaxis (GO:0048245) | 4.46652118 |
| 10 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.45297710 |
| 11 | regulation of lymphocyte chemotaxis (GO:1901623) | 4.39107040 |
| 12 | cellular response to interleukin-15 (GO:0071350) | 4.32243571 |
| 13 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 4.17369502 |
| 14 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.12233230 |
| 15 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.08208077 |
| 16 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.05277543 |
| 17 | eosinophil migration (GO:0072677) | 4.01611233 |
| 18 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.99152768 |
| 19 | regulation of chronic inflammatory response (GO:0002676) | 3.98748597 |
| 20 | negative regulation of viral genome replication (GO:0045071) | 3.95839378 |
| 21 | T cell migration (GO:0072678) | 3.93755017 |
| 22 | negative T cell selection (GO:0043383) | 3.91824183 |
| 23 | activated T cell proliferation (GO:0050798) | 3.91308229 |
| 24 | regulation of activation of Janus kinase activity (GO:0010533) | 3.90831952 |
| 25 | sequestering of actin monomers (GO:0042989) | 3.89410994 |
| 26 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.77709881 |
| 27 | regulation of T cell chemotaxis (GO:0010819) | 3.76812146 |
| 28 | positive regulation of T cell chemotaxis (GO:0010820) | 3.76812146 |
| 29 | cytolysis (GO:0019835) | 3.75995823 |
| 30 | positive regulation of defense response to virus by host (GO:0002230) | 3.75911494 |
| 31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.73300446 |
| 32 | platelet dense granule organization (GO:0060155) | 3.71303589 |
| 33 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.66523238 |
| 34 | response to interleukin-15 (GO:0070672) | 3.66346371 |
| 35 | positive regulation of lymphocyte migration (GO:2000403) | 3.65032539 |
| 36 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.63225227 |
| 37 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.63225227 |
| 38 | macrophage chemotaxis (GO:0048246) | 3.62994225 |
| 39 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.62705229 |
| 40 | lymphocyte chemotaxis (GO:0048247) | 3.55256975 |
| 41 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.51490337 |
| 42 | thymic T cell selection (GO:0045061) | 3.48044761 |
| 43 | positive regulation of cell killing (GO:0031343) | 3.42685256 |
| 44 | positive regulation of translational initiation (GO:0045948) | 3.40092060 |
| 45 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.40048579 |
| 46 | negative regulation of viral transcription (GO:0032897) | 3.38534125 |
| 47 | regulation of interleukin-8 secretion (GO:2000482) | 3.35543502 |
| 48 | regulation of regulatory T cell differentiation (GO:0045589) | 3.35376892 |
| 49 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.34854874 |
| 50 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.24526429 |
| 51 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.21643256 |
| 52 | regulation of cell killing (GO:0031341) | 3.21061923 |
| 53 | positive regulation of prostaglandin secretion (GO:0032308) | 3.17891071 |
| 54 | negative thymic T cell selection (GO:0045060) | 3.17214321 |
| 55 | regulation of T cell tolerance induction (GO:0002664) | 3.13853310 |
| 56 | regulation of T cell apoptotic process (GO:0070232) | 3.10806368 |
| 57 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.08492873 |
| 58 | positive regulation of T cell apoptotic process (GO:0070234) | 3.08228873 |
| 59 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.05021961 |
| 60 | cellular defense response (GO:0006968) | 3.04116987 |
| 61 | T cell selection (GO:0045058) | 3.03160023 |
| 62 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.00946857 |
| 63 | pyrimidine ribonucleoside metabolic process (GO:0046131) | 3.00343771 |
| 64 | regulation of calcium-mediated signaling (GO:0050848) | 3.00070670 |
| 65 | pyrimidine-containing compound catabolic process (GO:0072529) | 2.94542303 |
| 66 | positive regulation of tolerance induction (GO:0002645) | 2.93962314 |
| 67 | modulation by host of symbiont transcription (GO:0052472) | 2.93656726 |
| 68 | modulation by host of viral transcription (GO:0043921) | 2.93656726 |
| 69 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.93453036 |
| 70 | lymphocyte migration (GO:0072676) | 2.92153703 |
| 71 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.89157284 |
| 72 | regulation of viral genome replication (GO:0045069) | 2.88676867 |
| 73 | nucleoside diphosphate catabolic process (GO:0009134) | 2.87986074 |
| 74 | T cell receptor signaling pathway (GO:0050852) | 2.87713304 |
| 75 | response to interferon-beta (GO:0035456) | 2.87112011 |
| 76 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.86867329 |
| 77 | proteasome assembly (GO:0043248) | 2.85969677 |
| 78 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.84182552 |
| 79 | iron-sulfur cluster assembly (GO:0016226) | 2.82848677 |
| 80 | metallo-sulfur cluster assembly (GO:0031163) | 2.82848677 |
| 81 | natural killer cell activation (GO:0030101) | 2.81317430 |
| 82 | modulation of transcription in other organism involved in symbiotic interaction (GO:0052312) | 2.80755900 |
| 83 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.77011514 |
| 84 | regulation of lymphocyte migration (GO:2000401) | 2.76169319 |
| 85 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.75992976 |
| 86 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.73411381 |
| 87 | behavioral response to nicotine (GO:0035095) | 2.69961065 |
| 88 | L-fucose catabolic process (GO:0042355) | 2.69312644 |
| 89 | fucose catabolic process (GO:0019317) | 2.69312644 |
| 90 | L-fucose metabolic process (GO:0042354) | 2.69312644 |
| 91 | negative regulation of viral process (GO:0048525) | 2.69223891 |
| 92 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.68051126 |
| 93 | positive regulation of lamellipodium assembly (GO:0010592) | 2.65561115 |
| 94 | positive regulation of T cell migration (GO:2000406) | 2.64420037 |
| 95 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.62686988 |
| 96 | cytidine deamination (GO:0009972) | 10.8918354 |
| 97 | cytidine metabolic process (GO:0046087) | 10.8918354 |
| 98 | cytidine catabolic process (GO:0006216) | 10.8918354 |
| 99 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 10.3809436 |
| 100 | DNA deamination (GO:0045006) | 10.0756548 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.90347828 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.58478490 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.26060266 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.03440367 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.85023609 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.74661003 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.71327933 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.54942170 |
| 9 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.25657732 |
| 10 | VDR_22108803_ChIP-Seq_LS180_Human | 3.20409806 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.95206946 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.77952526 |
| 13 | MYB_26560356_Chip-Seq_TH2_Human | 2.49183939 |
| 14 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.42007167 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.28071438 |
| 16 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.23401346 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22993274 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.22047489 |
| 19 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.11082823 |
| 20 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.05622410 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98131682 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.81702378 |
| 23 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.78963555 |
| 24 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.78295773 |
| 25 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.76262008 |
| 26 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72630354 |
| 27 | GATA3_26560356_Chip-Seq_TH2_Human | 1.71745001 |
| 28 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.70166423 |
| 29 | MYB_26560356_Chip-Seq_TH1_Human | 1.68519209 |
| 30 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.64794540 |
| 31 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.50809850 |
| 32 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.48847578 |
| 33 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.47007263 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.42096609 |
| 35 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.41202788 |
| 36 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.41145984 |
| 37 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.39495060 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.35257441 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.33332646 |
| 40 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.31621665 |
| 41 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.30448273 |
| 42 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.29181378 |
| 43 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.28729964 |
| 44 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.27329067 |
| 45 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.24726763 |
| 46 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24380027 |
| 47 | MAF_26560356_Chip-Seq_TH1_Human | 1.24003616 |
| 48 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.22880810 |
| 49 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.21892396 |
| 50 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.20629009 |
| 51 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.19988969 |
| 52 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.17729945 |
| 53 | MAF_26560356_Chip-Seq_TH2_Human | 1.14587559 |
| 54 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14521822 |
| 55 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14336305 |
| 56 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.14218982 |
| 57 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.13811019 |
| 58 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.13265933 |
| 59 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.12521258 |
| 60 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.11939979 |
| 61 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.11685940 |
| 62 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.11605869 |
| 63 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.09551565 |
| 64 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09242653 |
| 65 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.07498090 |
| 66 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.06780015 |
| 67 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.03612648 |
| 68 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.03612648 |
| 69 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.03527411 |
| 70 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02624304 |
| 71 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.02470055 |
| 72 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.01408357 |
| 73 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.00388839 |
| 74 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.00115272 |
| 75 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.99905181 |
| 76 | NCOR_22424771_ChIP-Seq_293T_Human | 0.98451377 |
| 77 | AR_20517297_ChIP-Seq_VCAP_Human | 0.96389484 |
| 78 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.95941401 |
| 79 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.95941401 |
| 80 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.95863602 |
| 81 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.94496236 |
| 82 | P300_27268052_Chip-Seq_Bcells_Human | 0.92909489 |
| 83 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.92168871 |
| 84 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86749340 |
| 85 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.86642788 |
| 86 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.85799735 |
| 87 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.85737046 |
| 88 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.85021069 |
| 89 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.84098679 |
| 90 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.83676353 |
| 91 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83421630 |
| 92 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.82678380 |
| 93 | ERA_21632823_ChIP-Seq_H3396_Human | 0.79816645 |
| 94 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.78565157 |
| 95 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.78324244 |
| 96 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.78028357 |
| 97 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.76817152 |
| 98 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.76280321 |
| 99 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.76201318 |
| 100 | GATA3_26560356_Chip-Seq_TH1_Human | 0.75623865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.81284878 |
| 2 | MP0003763_abnormal_thymus_physiology | 3.56237244 |
| 3 | MP0002102_abnormal_ear_morphology | 3.01706919 |
| 4 | MP0009785_altered_susceptibility_to | 2.97310017 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.96200598 |
| 6 | MP0009333_abnormal_splenocyte_physiolog | 2.93138183 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.86258932 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.69044162 |
| 9 | MP0005377_hearing/vestibular/ear_phenot | 2.58123165 |
| 10 | MP0003878_abnormal_ear_physiology | 2.58123165 |
| 11 | MP0006072_abnormal_retinal_apoptosis | 2.56073806 |
| 12 | MP0002166_altered_tumor_susceptibility | 2.52193461 |
| 13 | MP0002723_abnormal_immune_serum | 2.42259512 |
| 14 | MP0001800_abnormal_humoral_immune | 2.35951467 |
| 15 | MP0002420_abnormal_adaptive_immunity | 2.33260352 |
| 16 | MP0003866_abnormal_defecation | 2.28343573 |
| 17 | MP0001819_abnormal_immune_cell | 2.28237332 |
| 18 | MP0000685_abnormal_immune_system | 2.26423356 |
| 19 | MP0005025_abnormal_response_to | 2.17898567 |
| 20 | MP0006082_CNS_inflammation | 2.14503507 |
| 21 | MP0003045_fibrosis | 2.10962384 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.01367978 |
| 23 | MP0002452_abnormal_antigen_presenting | 1.99577663 |
| 24 | MP0001790_abnormal_immune_system | 1.98254111 |
| 25 | MP0005387_immune_system_phenotype | 1.98254111 |
| 26 | MP0002006_tumorigenesis | 1.97599993 |
| 27 | MP0001501_abnormal_sleep_pattern | 1.95875595 |
| 28 | MP0003786_premature_aging | 1.85193010 |
| 29 | MP0002398_abnormal_bone_marrow | 1.82353870 |
| 30 | MP0000716_abnormal_immune_system | 1.73924578 |
| 31 | MP0005645_abnormal_hypothalamus_physiol | 1.72387114 |
| 32 | MP0003436_decreased_susceptibility_to | 1.59333254 |
| 33 | MP0001485_abnormal_pinna_reflex | 1.59235138 |
| 34 | MP0000703_abnormal_thymus_morphology | 1.56502102 |
| 35 | MP0004145_abnormal_muscle_electrophysio | 1.56423383 |
| 36 | MP0002419_abnormal_innate_immunity | 1.51818714 |
| 37 | MP0002722_abnormal_immune_system | 1.51608740 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.49931237 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.44539201 |
| 40 | MP0003195_calcinosis | 1.43961818 |
| 41 | MP0002405_respiratory_system_inflammati | 1.35853575 |
| 42 | MP0002429_abnormal_blood_cell | 1.34834241 |
| 43 | MP0001845_abnormal_inflammatory_respons | 1.34056065 |
| 44 | MP0001968_abnormal_touch/_nociception | 1.32874754 |
| 45 | MP0002138_abnormal_hepatobiliary_system | 1.30282059 |
| 46 | MP0002909_abnormal_adrenal_gland | 1.28829803 |
| 47 | MP0001986_abnormal_taste_sensitivity | 1.26792903 |
| 48 | MP0001905_abnormal_dopamine_level | 1.26408807 |
| 49 | MP0002736_abnormal_nociception_after | 1.25349601 |
| 50 | MP0004885_abnormal_endolymph | 1.23610195 |
| 51 | MP0002933_joint_inflammation | 1.21942517 |
| 52 | MP0003448_altered_tumor_morphology | 1.20701462 |
| 53 | MP0004147_increased_porphyrin_level | 1.19168031 |
| 54 | MP0008469_abnormal_protein_level | 1.18498938 |
| 55 | MP0001502_abnormal_circadian_rhythm | 1.16486693 |
| 56 | MP0005075_abnormal_melanosome_morpholog | 1.15364114 |
| 57 | MP0005253_abnormal_eye_physiology | 1.13678010 |
| 58 | MP0001919_abnormal_reproductive_system | 1.13606841 |
| 59 | MP0009764_decreased_sensitivity_to | 1.12974934 |
| 60 | MP0005379_endocrine/exocrine_gland_phen | 1.12241152 |
| 61 | MP0000372_irregular_coat_pigmentation | 1.08372233 |
| 62 | MP0006276_abnormal_autonomic_nervous | 1.07490732 |
| 63 | MP0002876_abnormal_thyroid_physiology | 1.06444371 |
| 64 | MP0005551_abnormal_eye_electrophysiolog | 1.05839046 |
| 65 | MP0008872_abnormal_physiological_respon | 1.04539771 |
| 66 | MP0009763_increased_sensitivity_to | 1.03232629 |
| 67 | MP0004947_skin_inflammation | 1.02457699 |
| 68 | MP0003724_increased_susceptibility_to | 1.02404837 |
| 69 | MP0008877_abnormal_DNA_methylation | 1.00830218 |
| 70 | MP0003011_delayed_dark_adaptation | 1.00580335 |
| 71 | MP0001853_heart_inflammation | 0.95132427 |
| 72 | MP0001661_extended_life_span | 0.93989999 |
| 73 | MP0001533_abnormal_skeleton_physiology | 0.92543989 |
| 74 | MP0008875_abnormal_xenobiotic_pharmacok | 0.91363535 |
| 75 | MP0001348_abnormal_lacrimal_gland | 0.86412814 |
| 76 | MP0002877_abnormal_melanocyte_morpholog | 0.86094586 |
| 77 | MP0005165_increased_susceptibility_to | 0.85789648 |
| 78 | MP0002733_abnormal_thermal_nociception | 0.83587117 |
| 79 | MP0000858_altered_metastatic_potential | 0.81023636 |
| 80 | MP0005389_reproductive_system_phenotype | 0.78660388 |
| 81 | MP0001765_abnormal_ion_homeostasis | 0.77420431 |
| 82 | MP0001542_abnormal_bone_strength | 0.77221582 |
| 83 | MP0005360_urolithiasis | 0.76355206 |
| 84 | MP0009745_abnormal_behavioral_response | 0.74730100 |
| 85 | MP0005166_decreased_susceptibility_to | 0.74207409 |
| 86 | MP0010386_abnormal_urinary_bladder | 0.72893042 |
| 87 | MP0005410_abnormal_fertilization | 0.72815223 |
| 88 | MP0002095_abnormal_skin_pigmentation | 0.72233736 |
| 89 | MP0002163_abnormal_gland_morphology | 0.70827319 |
| 90 | MP0001873_stomach_inflammation | 0.67173513 |
| 91 | MP0008007_abnormal_cellular_replicative | 0.66084407 |
| 92 | MP0000465_gastrointestinal_hemorrhage | 0.63885788 |
| 93 | MP0001970_abnormal_pain_threshold | 0.63158585 |
| 94 | MP0002019_abnormal_tumor_incidence | 0.62207382 |
| 95 | MP0001486_abnormal_startle_reflex | 0.62204917 |
| 96 | MP0002693_abnormal_pancreas_physiology | 0.61864282 |
| 97 | MP0006036_abnormal_mitochondrial_physio | 0.60976198 |
| 98 | MP0003137_abnormal_impulse_conducting | 0.58210126 |
| 99 | MP0005084_abnormal_gallbladder_morpholo | 0.57064867 |
| 100 | MP0004142_abnormal_muscle_tone | 0.56663615 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 5.65069626 |
| 2 | Abnormality of T cell number (HP:0011839) | 5.39203920 |
| 3 | IgG deficiency (HP:0004315) | 4.80122698 |
| 4 | Aplastic anemia (HP:0001915) | 4.40426143 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.30537764 |
| 6 | Severe combined immunodeficiency (HP:0004430) | 4.25722606 |
| 7 | Abnormality of T cells (HP:0002843) | 3.92815237 |
| 8 | Hypoproteinemia (HP:0003075) | 3.85761957 |
| 9 | Increased IgM level (HP:0003496) | 3.59205425 |
| 10 | Autoimmune hemolytic anemia (HP:0001890) | 3.54392361 |
| 11 | Abnormality of eosinophils (HP:0001879) | 3.44324547 |
| 12 | Thyroiditis (HP:0100646) | 3.34533574 |
| 13 | 3-Methylglutaconic aciduria (HP:0003535) | 3.32264464 |
| 14 | Abnormality of B cell number (HP:0010975) | 3.29705766 |
| 15 | Combined immunodeficiency (HP:0005387) | 3.28557738 |
| 16 | Abolished electroretinogram (ERG) (HP:0000550) | 3.21729167 |
| 17 | Mitochondrial inheritance (HP:0001427) | 3.21408611 |
| 18 | Abnormality of the prostate (HP:0008775) | 3.18638974 |
| 19 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.14816536 |
| 20 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.14816536 |
| 21 | Prostate neoplasm (HP:0100787) | 3.08082785 |
| 22 | Chronic diarrhea (HP:0002028) | 3.05365535 |
| 23 | B lymphocytopenia (HP:0010976) | 3.04790645 |
| 24 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.03464530 |
| 25 | Increased intramyocellular lipid droplets (HP:0012240) | 2.85394408 |
| 26 | Eosinophilia (HP:0001880) | 2.85317631 |
| 27 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.84704003 |
| 28 | Recurrent bronchitis (HP:0002837) | 2.84493540 |
| 29 | Decreased central vision (HP:0007663) | 2.83428589 |
| 30 | Acute necrotizing encephalopathy (HP:0006965) | 2.74637368 |
| 31 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.74339748 |
| 32 | Congenital stationary night blindness (HP:0007642) | 2.70340358 |
| 33 | Hepatocellular necrosis (HP:0001404) | 2.68423660 |
| 34 | Renal Fanconi syndrome (HP:0001994) | 2.62445592 |
| 35 | Hypoplasia of the thymus (HP:0000778) | 2.60960989 |
| 36 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.60949108 |
| 37 | Stomatitis (HP:0010280) | 2.60872313 |
| 38 | Cerebral hypomyelination (HP:0006808) | 2.59795680 |
| 39 | Pustule (HP:0200039) | 2.59331246 |
| 40 | Increased CSF lactate (HP:0002490) | 2.58530891 |
| 41 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.57003692 |
| 42 | Hepatic necrosis (HP:0002605) | 2.53500966 |
| 43 | Abnormality of T cell physiology (HP:0011840) | 2.49630020 |
| 44 | Increased hepatocellular lipid droplets (HP:0006565) | 2.48207656 |
| 45 | Type II lissencephaly (HP:0007260) | 2.46806433 |
| 46 | Lymphopenia (HP:0001888) | 2.46131018 |
| 47 | Leukocytosis (HP:0001974) | 2.45424143 |
| 48 | Renal cortical cysts (HP:0000803) | 2.44003155 |
| 49 | Panhypogammaglobulinemia (HP:0003139) | 2.42002352 |
| 50 | Myositis (HP:0100614) | 2.38489207 |
| 51 | Hemiplegia (HP:0002301) | 2.38474410 |
| 52 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.32755414 |
| 53 | Hypoalbuminemia (HP:0003073) | 2.32029277 |
| 54 | Abnormal albumin level (HP:0012116) | 2.32029277 |
| 55 | Attenuation of retinal blood vessels (HP:0007843) | 2.31187454 |
| 56 | Increased muscle lipid content (HP:0009058) | 2.28143945 |
| 57 | Cerebral edema (HP:0002181) | 2.24129417 |
| 58 | Oral leukoplakia (HP:0002745) | 2.16749872 |
| 59 | Vasculitis (HP:0002633) | 2.15695434 |
| 60 | Encephalitis (HP:0002383) | 2.15619530 |
| 61 | Increased serum lactate (HP:0002151) | 2.13905008 |
| 62 | Acute encephalopathy (HP:0006846) | 2.13803194 |
| 63 | Recurrent cutaneous fungal infections (HP:0011370) | 2.13579808 |
| 64 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.13579808 |
| 65 | Granulocytopenia (HP:0001913) | 2.13076780 |
| 66 | Optic neuritis (HP:0100653) | 2.09974974 |
| 67 | Retrobulbar optic neuritis (HP:0100654) | 2.09974974 |
| 68 | Lymphoma (HP:0002665) | 2.09371319 |
| 69 | Progressive macrocephaly (HP:0004481) | 2.09217546 |
| 70 | Pulmonary infiltrates (HP:0002113) | 2.08810858 |
| 71 | Meningitis (HP:0001287) | 2.07802138 |
| 72 | Lipid accumulation in hepatocytes (HP:0006561) | 2.07206590 |
| 73 | Hypergammaglobulinemia (HP:0010702) | 2.06885173 |
| 74 | Recurrent fungal infections (HP:0002841) | 2.06744569 |
| 75 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.05047247 |
| 76 | Optic disc pallor (HP:0000543) | 2.03741986 |
| 77 | Autoimmune thrombocytopenia (HP:0001973) | 2.00247732 |
| 78 | Pancreatic cysts (HP:0001737) | 1.99428772 |
| 79 | Pendular nystagmus (HP:0012043) | 1.95887117 |
| 80 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.94530411 |
| 81 | Palpebral edema (HP:0100540) | 1.94215313 |
| 82 | Keratoconjunctivitis (HP:0001096) | 1.92746240 |
| 83 | Delusions (HP:0000746) | 1.90687386 |
| 84 | Pancytopenia (HP:0001876) | 1.89694651 |
| 85 | Carpal bone hypoplasia (HP:0001498) | 1.86856426 |
| 86 | Amyotrophic lateral sclerosis (HP:0007354) | 1.80363942 |
| 87 | Lactic acidosis (HP:0003128) | 1.77397388 |
| 88 | Abnormality of the renal cortex (HP:0011035) | 1.77326319 |
| 89 | IgM deficiency (HP:0002850) | 1.77193904 |
| 90 | Agammaglobulinemia (HP:0004432) | 1.76706070 |
| 91 | Recurrent viral infections (HP:0004429) | 1.76387373 |
| 92 | True hermaphroditism (HP:0010459) | 1.74862627 |
| 93 | Constricted visual fields (HP:0001133) | 1.74481445 |
| 94 | Keratoconjunctivitis sicca (HP:0001097) | 1.72939107 |
| 95 | Generalized aminoaciduria (HP:0002909) | 1.72852275 |
| 96 | Retinal dysplasia (HP:0007973) | 1.72226073 |
| 97 | Abnormality of midbrain morphology (HP:0002418) | 1.71945372 |
| 98 | Molar tooth sign on MRI (HP:0002419) | 1.71945372 |
| 99 | Gangrene (HP:0100758) | 1.71448466 |
| 100 | Orchitis (HP:0100796) | 1.70475868 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.87543221 |
| 2 | KDR | 4.58478623 |
| 3 | TESK2 | 4.02233210 |
| 4 | TESK1 | 3.64941317 |
| 5 | STK16 | 3.23474950 |
| 6 | MAP3K12 | 3.07968048 |
| 7 | BCKDK | 3.02834736 |
| 8 | TAOK3 | 2.93811332 |
| 9 | ITK | 2.35245251 |
| 10 | BUB1 | 2.28756656 |
| 11 | ADRBK2 | 2.26247367 |
| 12 | MAP4K1 | 2.23673902 |
| 13 | MST4 | 2.22415800 |
| 14 | VRK2 | 2.21973814 |
| 15 | FES | 2.09010071 |
| 16 | GRK6 | 1.89116974 |
| 17 | ZAK | 1.86482045 |
| 18 | LIMK1 | 1.84358480 |
| 19 | TLK1 | 1.82367963 |
| 20 | TBK1 | 1.58628441 |
| 21 | EIF2AK3 | 1.53145264 |
| 22 | NUAK1 | 1.52966172 |
| 23 | WNK4 | 1.51087413 |
| 24 | SYK | 1.45503161 |
| 25 | VRK1 | 1.44211072 |
| 26 | DAPK1 | 1.35438559 |
| 27 | MYLK | 1.29556204 |
| 28 | MAPKAPK3 | 1.27618839 |
| 29 | TRIM28 | 1.22946399 |
| 30 | GRK1 | 1.22313520 |
| 31 | PRKCQ | 1.20250835 |
| 32 | CSK | 1.18409840 |
| 33 | ZAP70 | 1.14205364 |
| 34 | IKBKB | 1.08583275 |
| 35 | TIE1 | 1.03643480 |
| 36 | GRK7 | 1.03132848 |
| 37 | PINK1 | 1.02724103 |
| 38 | CSNK1G3 | 1.02605276 |
| 39 | PHKG1 | 1.00642170 |
| 40 | PHKG2 | 1.00642170 |
| 41 | IKBKE | 0.98155763 |
| 42 | TEC | 0.97190487 |
| 43 | MAP3K11 | 0.95973460 |
| 44 | LCK | 0.95668519 |
| 45 | JAK3 | 0.91220161 |
| 46 | CSF1R | 0.83138617 |
| 47 | LYN | 0.73972439 |
| 48 | CSNK1G2 | 0.70826474 |
| 49 | MAP4K2 | 0.70686039 |
| 50 | CLK1 | 0.69627094 |
| 51 | CSNK1G1 | 0.67150335 |
| 52 | BTK | 0.65448028 |
| 53 | CSNK1A1L | 0.63820370 |
| 54 | DYRK2 | 0.63439145 |
| 55 | MUSK | 0.63087070 |
| 56 | PLK2 | 0.63036636 |
| 57 | BLK | 0.60331671 |
| 58 | GRK5 | 0.56265275 |
| 59 | PIK3CG | 0.55681775 |
| 60 | MATK | 0.54552548 |
| 61 | RIPK4 | 0.52812931 |
| 62 | PIK3CA | 0.51968970 |
| 63 | EIF2AK2 | 0.51279885 |
| 64 | AURKA | 0.47657640 |
| 65 | DAPK3 | 0.45616371 |
| 66 | ILK | 0.44944149 |
| 67 | TAF1 | 0.44607075 |
| 68 | OXSR1 | 0.44309368 |
| 69 | ROCK1 | 0.44235834 |
| 70 | KIT | 0.43966843 |
| 71 | IGF1R | 0.43846990 |
| 72 | INSRR | 0.42664976 |
| 73 | TYRO3 | 0.42581106 |
| 74 | RPS6KA4 | 0.39293039 |
| 75 | MAPKAPK5 | 0.38670647 |
| 76 | MAP2K6 | 0.36632556 |
| 77 | STK39 | 0.36125384 |
| 78 | INSR | 0.35604982 |
| 79 | FYN | 0.34818703 |
| 80 | SCYL2 | 0.34704899 |
| 81 | RPS6KA5 | 0.34536482 |
| 82 | MAPKAPK2 | 0.34494886 |
| 83 | BMPR2 | 0.33981714 |
| 84 | ADRBK1 | 0.32072102 |
| 85 | JAK1 | 0.31103275 |
| 86 | PRKCA | 0.29935763 |
| 87 | PIM1 | 0.27168980 |
| 88 | PAK3 | 0.26384393 |
| 89 | NTRK1 | 0.25877200 |
| 90 | MAP2K7 | 0.25827161 |
| 91 | LMTK2 | 0.24997062 |
| 92 | BMPR1B | 0.24643912 |
| 93 | PRKACA | 0.24051772 |
| 94 | OBSCN | 0.23265183 |
| 95 | HCK | 0.22728632 |
| 96 | EPHA3 | 0.20861834 |
| 97 | CSNK2A1 | 0.20569212 |
| 98 | PRKCE | 0.20299192 |
| 99 | ALK | 0.20014469 |
| 100 | NEK9 | 0.19268055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.12488990 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 4.33898081 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.06981709 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.44127992 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.39078218 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.02530100 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.84501946 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.63500291 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.36627846 |
| 10 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.35704279 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.23311611 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.21188857 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.18823059 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.18303332 |
| 15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.91490189 |
| 16 | Protein export_Homo sapiens_hsa03060 | 1.72101379 |
| 17 | Asthma_Homo sapiens_hsa05310 | 1.71856217 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.69455502 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.64167385 |
| 20 | Salmonella infection_Homo sapiens_hsa05132 | 1.54837942 |
| 21 | Alzheimers disease_Homo sapiens_hsa05010 | 1.50784169 |
| 22 | RNA polymerase_Homo sapiens_hsa03020 | 1.50729457 |
| 23 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.48143648 |
| 24 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.45227371 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.42317734 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.37752140 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.36063775 |
| 28 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.33847911 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.28995756 |
| 30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.27819041 |
| 31 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.25486271 |
| 32 | Huntingtons disease_Homo sapiens_hsa05016 | 1.18406510 |
| 33 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.17227313 |
| 34 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.13072467 |
| 35 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.04301825 |
| 36 | Phototransduction_Homo sapiens_hsa04744 | 1.00620406 |
| 37 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.95506643 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.92754142 |
| 39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.90714596 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 0.89859421 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 0.86392620 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.84355354 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.80548594 |
| 44 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76712726 |
| 45 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.74246806 |
| 46 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.73779303 |
| 47 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.73755745 |
| 48 | Malaria_Homo sapiens_hsa05144 | 0.63698729 |
| 49 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.63629059 |
| 50 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.61304367 |
| 51 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.59714715 |
| 52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.59102129 |
| 53 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57778834 |
| 54 | Purine metabolism_Homo sapiens_hsa00230 | 0.57374582 |
| 55 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.57137390 |
| 56 | Legionellosis_Homo sapiens_hsa05134 | 0.56289569 |
| 57 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.51493444 |
| 58 | Basal transcription factors_Homo sapiens_hsa03022 | 0.50815101 |
| 59 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.49502297 |
| 60 | Apoptosis_Homo sapiens_hsa04210 | 0.48774327 |
| 61 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.46466592 |
| 62 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45380605 |
| 63 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.45244996 |
| 64 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.44497912 |
| 65 | Ribosome_Homo sapiens_hsa03010 | 0.42852525 |
| 66 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.38233019 |
| 67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.37057292 |
| 68 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.37029087 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.36683198 |
| 70 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35912714 |
| 71 | Spliceosome_Homo sapiens_hsa03040 | 0.35891126 |
| 72 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.35053415 |
| 73 | RNA degradation_Homo sapiens_hsa03018 | 0.33505911 |
| 74 | Leishmaniasis_Homo sapiens_hsa05140 | 0.33387056 |
| 75 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.32989239 |
| 76 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.32595517 |
| 77 | Olfactory transduction_Homo sapiens_hsa04740 | 0.32559580 |
| 78 | Retinol metabolism_Homo sapiens_hsa00830 | 0.32470582 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.32300277 |
| 80 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.32242413 |
| 81 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.31092617 |
| 82 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.29857256 |
| 83 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.28443453 |
| 84 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.27672214 |
| 85 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.26663741 |
| 86 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.26632875 |
| 87 | Pertussis_Homo sapiens_hsa05133 | 0.25549932 |
| 88 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.23185692 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.23022696 |
| 90 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.22115564 |
| 91 | Alcoholism_Homo sapiens_hsa05034 | 0.22028975 |
| 92 | RNA transport_Homo sapiens_hsa03013 | 0.21956935 |
| 93 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.21418451 |
| 94 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.20896083 |
| 95 | Mismatch repair_Homo sapiens_hsa03430 | 0.19814006 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.19741503 |
| 97 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.19323704 |
| 98 | Lysosome_Homo sapiens_hsa04142 | 0.19053719 |
| 99 | Homologous recombination_Homo sapiens_hsa03440 | 0.18401577 |
| 100 | HTLV-I infection_Homo sapiens_hsa05166 | 0.17921434 |

